Association study between glutathione S-transferase GST-M1 GST-T1, and GST-P1 polymorphisms and tardive dyskinesia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, Seung-Gul | - |
dc.contributor.author | Lee, Heon-Jeong | - |
dc.contributor.author | Choi, Jung-Eun | - |
dc.contributor.author | An, Hyonggin | - |
dc.contributor.author | Rhee, MinKyu | - |
dc.contributor.author | Kim, Leen | - |
dc.date.accessioned | 2021-09-08T21:05:36Z | - |
dc.date.available | 2021-09-08T21:05:36Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2009-01 | - |
dc.identifier.issn | 0885-6222 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/120823 | - |
dc.description.abstract | Objectives Data front several studies suggest that oxidative stress may play a role in the pathophysiology of tardive dyskinesia (TD). Glutathione S-transferase (GST) enzymes play important roles in protecting cells against oxidative stress. In the present study. we investigated the hypothesis that polymorphisms in genes for these detoxifying enzymes can influence susceptibility to TD in patients with schizophrenia. Methods The GST-M1, GST-T1, and GST-P1 loci were analyzed by polymerase chain reaction (PCR)-based methods in 83 schizophrenic patients with TD and 126 schizophrenic without TD who were matched for antipsychotic drug exposure and other relevant variables. The multifactor dimensionality reduction (MDR) approach was used to analyze gene-gene interactions. Results There were no significant differences in the distributions of the GST-M1, GST-T1, and GST-P1 genotypes between the TD and non-TD groups (p > 0.05). However. in comparison of the severity of TD among genotypes using Poisson regression showed that lle/lle genotype of GST-P1 had higher AIMS score compared to lle/Va + Val/Val genotypes (X-2 = 7.13, p = 0.008). MDR analysis did not show a significant interaction between the three GST gene variants and susceptibility to TD (p > 0.05). Conclusions These results suggest that GST gene polymorphisms do not confer increased susceptibility to TD in patients with schizophrenia but TD severity might be related with GST-P1 variants. Copyright (c) 2008 John Wiley & Sons, Ltd. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.subject | MULTIFACTOR-DIMENSIONALITY REDUCTION | - |
dc.subject | GENE-GENE INTERACTIONS | - |
dc.subject | MANGANESE SUPEROXIDE-DISMUTASE | - |
dc.subject | RECEPTOR GENE | - |
dc.subject | CHRONIC-SCHIZOPHRENIA | - |
dc.subject | NO ASSOCIATION | - |
dc.subject | ALA-9VAL POLYMORPHISM | - |
dc.subject | MULTIPLE-SCLEROSIS | - |
dc.subject | KOREAN POPULATION | - |
dc.subject | VITAMIN-E | - |
dc.title | Association study between glutathione S-transferase GST-M1 GST-T1, and GST-P1 polymorphisms and tardive dyskinesia | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Heon-Jeong | - |
dc.contributor.affiliatedAuthor | An, Hyonggin | - |
dc.contributor.affiliatedAuthor | Kim, Leen | - |
dc.identifier.doi | 10.1002/hup.988 | - |
dc.identifier.scopusid | 2-s2.0-60549083292 | - |
dc.identifier.wosid | 000262707100007 | - |
dc.identifier.bibliographicCitation | HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, v.24, no.1, pp.55 - 60 | - |
dc.relation.isPartOf | HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL | - |
dc.citation.title | HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL | - |
dc.citation.volume | 24 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 55 | - |
dc.citation.endPage | 60 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalResearchArea | Psychology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Psychology | - |
dc.subject.keywordPlus | MULTIFACTOR-DIMENSIONALITY REDUCTION | - |
dc.subject.keywordPlus | GENE-GENE INTERACTIONS | - |
dc.subject.keywordPlus | MANGANESE SUPEROXIDE-DISMUTASE | - |
dc.subject.keywordPlus | RECEPTOR GENE | - |
dc.subject.keywordPlus | CHRONIC-SCHIZOPHRENIA | - |
dc.subject.keywordPlus | NO ASSOCIATION | - |
dc.subject.keywordPlus | ALA-9VAL POLYMORPHISM | - |
dc.subject.keywordPlus | MULTIPLE-SCLEROSIS | - |
dc.subject.keywordPlus | KOREAN POPULATION | - |
dc.subject.keywordPlus | VITAMIN-E | - |
dc.subject.keywordAuthor | tardive dyskinesia | - |
dc.subject.keywordAuthor | schizophrenia | - |
dc.subject.keywordAuthor | glutathione S-transferase | - |
dc.subject.keywordAuthor | polymorphism | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.